Cronus Research Labs Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-11-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -43.36%
(FY 2023)
- Profit 98.55%
(FY 2023)
- Ebitda 91.09%
(FY 2023)
- Net Worth -0.52%
(FY 2023)
- Total Assets -0.54%
(FY 2023)
About Cronus Research Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kavuru Kumar, Mallemputi Chowdary, and Abbavaram Sudheer serve as directors at the Company.
- CIN/LLPIN
U73100TG2014PTC096110
- Company No.
096110
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2014
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cronus Research Labs Private Limited offer?
Cronus Research Labs Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Syringes.
Who are the key members and board of directors at Cronus Research Labs?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mallemputi Chowdary | Director | 24-Oct-2014 | Current |
Kavuru Kumar | Director | 24-Oct-2014 | Current |
Abbavaram Sudheer | Director | 08-Feb-2017 | Current |
Financial Performance of Cronus Research Labs.
Cronus Research Labs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 43.36% decrease. The company also saw a substantial improvement in profitability, with a 98.55% increase in profit. The company's net worth dipped by a decrease of 0.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Cronus Research Labs?
In 2023, Cronus Research Labs had a promoter holding of 40.00% and a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Cronus Pharma Specialities India Private LimitedActive 9 years 3 months
Kavuru Kumar and Mallemputi Chowdary are mutual person
- Gensource Pharma Solutions Private LimitedActive 14 years 9 months
Kavuru Kumar and Mallemputi Chowdary are mutual person
- Plerum Infra Projects Private LimitedActive 7 years 9 months
Kavuru Kumar and Abbavaram Sudheer are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cronus Research Labs?
Cronus Research Labs has a workforce of 6 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cronus Research Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cronus Research Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.